Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Alexandra P. Wolanskyj"'
Autor:
Clifford M. Csizmar, Antoine N. Saliba, Patricia T. Greipp, Hassan Alkhateeb, Kebede H. Begna, James M. Foran, Naseema Gangat, William J. Hogan, C. Christopher Hook, Mark R. Litzow, Abhishek A. Mangaonkar, Jeanne M. Palmer, Animesh Pardanani, Mithun V. Shah, Ayalew Tefferi, Mehrdad Hefazi Torghabeh, Alexandra P. Wolanskyj-Spinner, Mrinal M. Patnaik, Scott H Kaufmann, Aref Al-Kali
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/aed91acc184e4fa6b1a7c4380916eac0
Autor:
Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H. Begna, Michelle A. Elliott, Alexandra P. Wolanskyj-Spinner, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract We describe 1000 patients with essential thrombocythemia seen at the Mayo Clinic between 1967 and 2023: median age 58 years (18–90), females 63%, JAK2/CALR/MPL-mutated 62%/27%/3%, triple-negative (TN) 8%, extreme thrombocytosis (ExT; plate
Externí odkaz:
https://doaj.org/article/e48103f0b32f4105bb18f282364988d9
Autor:
Naseema Gangat, Yamna Jadoon, Natasha Szuber, Curtis A. Hanson, Alexandra P. Wolanskyj-Spinner, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 3, Pp 1-9 (2022)
Abstract Cytogenetic studies among 809 consecutive patients with essential thrombocythemia (ET; median age 59 years; 65% females) revealed normal karyotype in 754 (93%), loss of chromosome Y only (-Y) in 16 (2%), and abnormalities other than -Y in 39
Externí odkaz:
https://doaj.org/article/20b2787130e44720a42b7db77e81b831
Autor:
Kebede H. Begna, Walid Ali, Naseema Gangat, Michelle A. Elliott, Aref Al-Kali, Mark R. Litzow, C. Christopher Hook, Alexandra P. Wolanskyj-Spinner, William J. Hogan, Mrinal M. Patnaik, Animesh Pardanani, Darci L. Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-8 (2021)
Abstract Between 2004 and 2017, a total of 1123 adult patients (median age 65 years; 61% males) with newly diagnosed acute myeloid leukemia (AML), not including acute promyelocytic leukemia, were seen at the Mayo Clinic. Treatment included intensive
Externí odkaz:
https://doaj.org/article/8c1ea1c8f3b14264857ccad9a27ab4b5
Autor:
Rachel D. Havyer, Suzanne M. Norby, Andrea N. Leep Hunderfund, Stephanie R. Starr, Tara R. Lang, Alexandra P. Wolanskyj, Darcy A. Reed
Publikováno v:
BMC Medical Education, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background The changing healthcare landscape requires physicians to develop new knowledge and skills such as high-value care, systems improvement, population health, and team-based care, which together may be referred to as the Science of He
Externí odkaz:
https://doaj.org/article/e39ae8f4c6c94c4bbf1e8ec942374d0a
Publikováno v:
Case Reports in Hematology, Vol 2013 (2013)
Shapiro syndrome and periodic hypothermia have been reported approximately fifty times in the literature. Shapiro syndrome is defined as the constellation of periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro
Externí odkaz:
https://doaj.org/article/258c7ab64b1b4eccb1d7baf105458f44
Publikováno v:
Hematology Reports, Vol 2, Iss 1, Pp e6-e6 (2010)
Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare,
Externí odkaz:
https://doaj.org/article/e5da4a94125241b98f2f96888165baec
Autor:
John McGlothlin, Jithma P. Abeykoon, Eyad Al-Hattab, Aneel A. Ashrani, Michelle A Elliott, Ronald Go, C. Christopher Hook, Animesh Pardanani, Rajiv K. Pruthi, Meera Sridharan, Alexandra P. Wolanskyj
Publikováno v:
Blood. 140:5328-5330
Publikováno v:
Hematology/Oncology Clinics of North America. 36:365-380
Over the past decade, the role of immunotherapy treatment in cancer has expanded; specifically, indications for immune checkpoint inhibitors (ICI) have multiplied and are used as first-line therapy. ICIs include cytotoxic T-lymphocyte-associated prot
Autor:
Curtis A. Hanson, Mark R. Litzow, Alexandra P. Wolanskyj, Aref Al-Kali, Mrinal M. Patnaik, William J. Hogan, Michelle A. Elliott, Naseema Gangat, Jaya Kittur, Animesh Pardanani, Matthew T. Howard, C. Christopher Hook, Kebede H. Begna, Ayalew Tefferi, Jennifer C. Yui, Rhett P. Ketterling
Publikováno v:
British Journal of Haematology. 195:413-416
Institutional database search (1999-2020) for acute myeloid leukaemia (AML) identified 109 cases of myeloid sarcoma (MS), of which 19 were isolated and presented de novo. The latter displayed longer survival (median 78 months), compared to MS with sy